Retail prices on several anti-cancer medications slashed
The retail prices of some anti-cancer drugs have been cut by 87 percent by the drug price control authority in India.
List view / Grid view
News
FDA sends warning letter to Canadian OTC manufacturer
FDA sends warning to Petra Hygienic Systems Int LTD after they find violations of current good manufacturing practices (cGMPs).
Patent litigation for adalimumab resolved in the US
AbbVie has announced that it has resolved its US HUMIRA (adalimumab) litigation with Boehringer Ingelheim.
Four drug companies accused of illegal market sharing
The CMA accuses four pharmaceutical firms of colluding to illegally inflate prices of an anti-nausea drug.
Mirikizimab moved to Phase III after positive trial findings
Eli Lilly presents new data for their mirikizimab treatment for Crohn’s disease.
Single vaccination approach developed to combat respiratory diseases
Scientists have developed a single vaccination approach to simultaneously combat influenza and pneumococcal infections.
Pharmaceutical cleanroom monitoring software solution
Particle Measuring Systems releases the new Pharmaceutical Net® Pro Environmental Monitoring Software for FacilityPro® Environmental Monitoring Systems.
Platform launched to facilitate licensed import of medical cannabis in EU
The first platform to facilitate the licensed importation of medical cannabis into Europe has formally launched in the UK.
Connect 2 Cleanrooms and Elis Cleanroom announce partnership
Connect 2 Cleanrooms (C2C) and Elis Cleanroom have signed a partnership agreement on 18 May to further strengthen the contamination control solution packages offered to their customers.
More data needed for blister packages in nursing homes
New research shows that there is hardly any robust data from studies available on blister packaging for nursing homes.
Study shows that clinical research in England is ‘thriving’
Research shows that the NHS continues to provide the optimum environment for the life sciences industry to deliver research.
GSK and Novartis ‘misled’ consumers, says Federal Court of Australia
GSK and Novartis found to have misled consumers with the packaging and pricing of their osteoarthritis pain treatment.
Faulty barcode scans could cost the pharma industry billions
Pharmaceutical manufacturers and wholesale distributors could start losing billions of dollars because of faulty barcode scans.
Market for single-use bioprocessing systems in Asia Pacific rises
The single-use bioprocessing systems market in Asia Pacific has witnessed an impressive rise and is expected to continue growing.
Once-per-month HIV drugs could soon be available
According to a recent article, drug companies are developing longer-acting, injectable HIV treatments.
